bioRxivDevelopmental BiologyPreprint
Context-dependent requirement of H3K9 methyltransferase activity during cellular reprogramming to iPSCs
Simon E. Vidal, Alexander PolyzosiD, Jorge Morales-ValenciaiD, Hongsu WangiD, Emily SwanzeyiD, Ly-Sha EeiD, Bhishma Amlani, Shengjiang TuiD, Yixiao GongiD, Valentina SnetkovaiD, Jane A. SkokiD, Aristotelis TsirigosiD, Sang Yong KimiD, Effie ApostolouiD, Matthias StadtfeldiD
Abstract
Methylation of histone 3 at lysine 9 (H3K9) is widely regarded as a major roadblock for cellular reprogramming and interference with associated methyltransferases such as EHMT1 and EHMT2 (also known as GLP and G9A, respectively) increases the efficiencies at which induced pluripotent stem cells (iPSCs) can be derived. Activation of histone and DNA demethylases by ascorbic acid (AA) has become a common approach to facilitate the extensive epigenetic remodeling required for iPSC formation, but possible functional interactions between the H3K9 methylation machinery and AA-stimulated enzymes remain insufficiently explored. Here we show that reduction of EHMT1/2 activity counteracts iPSC formation in an optimized reprogramming system in the presence of AA. Mechanistically, EHMT1/2 activity under these conditions is required for efficient downregulation of somatic genes and transition into an epithelial state. Of note, transient inhibition of EHMT1/2 during reprogramming yields iPSCs that fail to efficiently give rise to viable mice, suggesting persistent molecular defects in these cells. Genetic interference with the H3K9 demethylase KDM3B ameliorated the adverse effect of EHMT1/2 inhibition on iPSC formation. Together, our observations document novel functions of H3K9 methyltransferases during iPSC formation and suggest that the balancing of AA-stimulated enzymes by EHMT1/2 supports efficient and error-free iPSC reprogramming to pluripotency.
- organism: mouse
- assay: DNA methylation
- assay: ChIP-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dot1L methyltransferase activity is a barrier to acquisition of pluripotency but not transdifferentiation
Coral K. Wille, Rupa Sridharan·Stem Cell ReportsPeer-reviewed·Jan 6, 2022
- Catalytic inhibition of H3K9me2 writers disturbs epigenetic marks during bovine nuclear reprogramming.
Rafael Vilar Sampaio, Juliano Rodrigues Sangalli, … Flávio Vieira Meirelles·Scientific ReportsPeer-reviewed·Jul 13, 2020
- DOT1L interaction partner AF10 controls patterning of H3K79 methylation and RNA polymerase II to maintain cell identity
Coral K. Wille, Edwin N. Neumann, … Rupa Sridharan·Stem Cell ReportsPeer-reviewed·Nov 22, 2023
- Histone demethylase complexes KDM3A and KDM3B cooperate with OCT4/SOX2 to construct pluripotency gene regulatory network
- Antagonistic H3K79me-H3K9ac crosstalk determines elongation at housekeeping genes to promote pluripotency
Coral K. Wille, Xiaoya Zhang, … Rupa Sridharan·Science AdvancesPeer-reviewed·Nov 17, 2023
- AF10 (MLLT10) prevents somatic cell reprogramming through regulation of H3K79 methylation
Deniz Uğurlu-Çimen, Deniz Odluyurt, … Tamer T. Önder·Epigenetics & ChromatinPeer-reviewed·Jul 2, 2021